Talis Biomedical Corporation (NASDAQ: TLIS)
$8.66
+0.2200 ( +2.61% ) 1.6K
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.
Market Data
Open
$8.66
Previous close
$8.44
Volume
1.6K
Market cap
$15.94M
Day range
$8.61 - $8.78
52 week range
$4.35 - $9.60
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 12 | Jun 25, 2024 |
| 8-k | 8K-related | 12 | Jun 03, 2024 |
| 10-q | Quarterly Reports | 53 | May 08, 2024 |
| 8-k | 8K-related | 12 | May 03, 2024 |
| 8-k | 8K-related | 11 | Apr 11, 2024 |
| 10-k | Annual reports | 73 | Mar 28, 2024 |
| 8-k | 8K-related | 10 | Jan 26, 2024 |
| 8-k | 8K-related | 13 | Nov 14, 2023 |
| 10-q | Quarterly Reports | 55 | Nov 14, 2023 |
| 8-k | 8K-related | 12 | Sep 01, 2023 |